Boundless Bio is a pioneering biotechnology company focusing on exploring and developing therapeutics targeting extrachromosomal DNA in aggressive cancers.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!